New Anti-Alzheimer Drugs from Biodiversity: The Role of the Natural Acetylcholinesterase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 10, 2005-10 ,pp. : 915-926

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Anti-Amyloid Therapy for Alzheimer’s Disease: From Secretase Modulators to Polymerisation Inhibitors

By Aisen Paul S.  

CNS Drugs, Vol. 19, Iss. 12, 2005-01 ,pp. : 989-996

Adis International

Access to resources Recommend Favorite

Role of Nanomedicines in Delivery of Anti-Acetylcholinesterase Compounds to the Brain in Alzheimer’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 8, 2014-10 ,pp. : 1315-1324

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-inflammatory drugs: a hope for Alzheimer’s disease?

By Hüll M.   Lieb K.   Fiebich B.L.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 671-683

Informa Healthcare

Access to resources Recommend Favorite

Multidrug resistance (MDR) in cancer - Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

By Krishna R.   Mayer L.D.  

European Journal of Pharmaceutical Sciences, Vol. 11, Iss. 4, 2000-10 ,pp. : 265-283

Elsevier

Access to resources Recommend Favorite